We are an R&D-stage manufacturer committed to cost reduction and innovation through the utilization of lean evidence-based business practices. We believe innovation is driven through lean manufacturing initiatives, strategic collaboration, and efficiency in design and delivery. Through careful project development planning, we can advance products from concept to commercialization quicker and with far less capital than our counterparts. We are intensely focused on capital efficiency and time to market.
UNMET CRITICAL NEEDS
Increase cost-effectiveness through improvements to existing or new platform technologies.
Favor products eligible for FDA 510(k) pathway, with or without clinical safety studies, to achieve the quickest path to initial regulatory clearance.
Focus primarily on single-use products not requiring significant capital equipment with strong intellectual property, low-to-moderate technological complexity and manufacturing costs.
Rapid prototype and product development based on market feedback.
ACCELERATE REVENUE GROWTH
Expand marketing and clinical training.
Leverage sales and marketing power of larger corporate partner, if applicable.
Utilize independent distribution network to establish traction.
Acquisition/licensing of product by corporate partner.